Is reconstitution on the current PTCE?
Stability of reconstitutable products is in Knowledge Area 1.7. That means beyond-use time and storage after a manufacturer product is mixed as labeled. Procedures to compound nonsterile products, and physical/chemical incompatibilities written as compounding steps, were removed from the PTCE outline effective January 2026.
PTCB, PTCE Job Analysis Study (outline changes effective January 2026)
Same domain
- What brand, generic, and classification knowledge is on the PTCE?
- What is a therapeutic duplication on the PTCE?
- Which interaction types appear on the PTCE?
- How are strengths, doses, and dosage forms tested?
- What special handling and administration instructions are in scope?
- How does the PTCE treat side effects, adverse effects, and allergies?
- Are medication indications on the PTCE?
- What stability facts are tested for insulin, suspensions, and injectables?
- What storage conditions does the PTCE expect?